← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nextrast, Inc.
Hillsborough, CA
$5,763,313
Total funding
4
Grants
Funding over time
peak $1.1M · FY2014–22$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,763,313 · 4
By mechanism
R44$4,051,871 · 2
R42$1,478,091 · 1
R41$233,351 · 1
Investigators at Nextrast, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Vascular CT contrast agent development$843,622
R44 · FY2021 · HL
Vascular CT contrast agent development$821,821
R44 · FY2022 · HL
Novel Bowel Contrast Agent for Dual Energy CT$597,798
R44 · FY2016 · DK
Novel Bowel Contrast Agent for Dual Energy CT$594,627
R44 · FY2017 · DK
Novel Bowel Contrast Agent for Dual Energy CT$594,198
R44 · FY2018 · DK
Augmenting Dual Energy CT for Novel Contrast Agents$499,999
R42 · FY2017 · DK
Augmenting Dual Energy CT for Novel Contrast Agents$489,046
R42 · FY2018 · DK
Augmenting Dual Energy CT for Novel Contrast Agents$489,046
R42 · FY2019 · DK
Novel Bowel Contrast Agent for Dual Energy CT$349,825
R44 · FY2015 · DK
Vascular CT contrast agent development$249,980
R44 · FY2020 · HL
Preclinical Efficacy of Silicon-based Dual Energy CT Contrast Material$233,351
R41 · FY2014 · DK